New allergy nasal spray good for eye symptoms
Newly approved Veramyst, a nasal spray containing fluticasone furoate, will not only improve nasal symptoms associated with allergies but also relieve allergic eye symptoms, according to manufacturer GlaxoSmithKline.
Newly approved Veramyst, a nasal spray containing fluticasone furoate, will not only improve nasal symptoms associated with allergies but also relieve allergic eye symptoms, according to manufacturer GlaxoSmithKline. The product is approved by the FDA for treating seasonal and perennial allergy symptoms in adults and children two years of age and older. Specifically, the spray has been shown to relieve nasal congestion; sneezing; runny, itchy nose; and red, itchy, and watery eyes. Veramyst will be available nationwide by late May 2007 and contains 27.5 mcg fluticasone furoate per 50-microliter spray. Each 10-gm bottle contains 120 sprays.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Exploring Challenges, Opportunities for Community Pharmacists in Tobacco Cessation
April 24th 2024By addressing integration barriers associated with implementing tobacco cessation programs in the community pharmacy, community pharmacists can “significantly impact public health by increasing access to effective cessation support,” wrote investigators.
